Anne Husebekk
Corporate Officer/Principal chez University of Tromso
Postes actifs de Anne Husebekk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| University of Tromso | Corporate Officer/Principal | - | - |
Historique de carrière de Anne Husebekk
Anciens postes connus de Anne Husebekk
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Prophylix AS
 Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Directeur des opérations | 01/01/2008 | - |
| Fondateur | 01/01/2008 | - |
Formation de Anne Husebekk
| University of Tromso | Doctorate Degree |
Statistiques
Internationale
| Norvège | 3 |
Opérationnelle
| Corporate Officer/Principal | 1 |
| Doctorate Degree | 1 |
| Chief Operating Officer | 1 |
Sectorielle
| Consumer Services | 2 |
| Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Entreprise privées | 1 |
|---|---|
Prophylix AS
Prophylix AS Pharmaceuticals: MajorHealth Technology Prophylix AS operates as biotech company that offers orphan drug programs and follow-on therapy. The firm develops a prophylactic medicinal product to prevent newborns from Foetal/Neonatal Alloimmune Thrombocytopenia (FNAIT). The company was founded by Bjørn Ragnar Skogen, Jens Kjeldsen-Kragh, Anne Husebekk, and Mette Kjaer in 2008 and is headquartered in Tromso, Norway. | Health Technology |
- Bourse
- Insiders
- Anne Husebekk
- Expérience
